80 related articles for article (PubMed ID: 11712303)
1. [The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia].
Rózański J
Ann Acad Med Stetin; 2000; 46():177-87. PubMed ID: 11712303
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of lidocaine and its active metabolite, monoethylglycinexylidide, after intravenous administration of lidocaine to awake and isoflurane-anesthetized cats.
Thomasy SM; Pypendop BH; Ilkiw JE; Stanley SD
Am J Vet Res; 2005 Jul; 66(7):1162-6. PubMed ID: 16111153
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
4. Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats.
Gawrońska-Szklarz B; Musiał DH; Pawlik A; Paprota B
Pol J Pharmacol; 2003; 55(4):619-24. PubMed ID: 14581721
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of lidocaine and its active metabolite monoethylglycinexylidide after a single intravenous administration in chickens (Gallus domesticus) anesthetized with isoflurane.
Da Cunha AF; Messenger KM; Stout RW; Barker SA; Nevarez JG; Queiroz-Williams P; Tully TN
J Vet Pharmacol Ther; 2012 Dec; 35(6):604-7. PubMed ID: 22212047
[No Abstract] [Full Text] [Related]
6. [Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans].
Górnik W
Ann Acad Med Stetin; 1996; 42():39-50. PubMed ID: 9199125
[TBL] [Abstract][Full Text] [Related]
7. [Lidocaine metabolism associated with epidural anesthesia in patients for hepatic surgery].
Sato T; Ono T; Ozaki M; Sakio H; Yasuda S
Masui; 1999 Dec; 48(12):1318-22. PubMed ID: 10658411
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
[TBL] [Abstract][Full Text] [Related]
9. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
Kupcová V; Turecký L; Szántová M; Schmidtová K
Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
[TBL] [Abstract][Full Text] [Related]
10. [Serum concentration of lidocaine and its active metabolite monoethylglycinexylidine during fiberoptic bronchoscopy under local anesthesia].
Milman N; Laub MS; Munch EP; Angelo HR
Ugeskr Laeger; 1991 Mar; 153(13):932-5. PubMed ID: 2024301
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
Ko JC; Maxwell LK; Abbo LA; Weil AB
J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.
Bennett PN; Aarons LJ; Bending MR; Steiner JA; Rowland M
J Pharmacokinet Biopharm; 1982 Jun; 10(3):265-81. PubMed ID: 7175699
[TBL] [Abstract][Full Text] [Related]
13. Effect of ciprofloxin on the pharmacokinetics of intravenous lidocaine.
Isohanni MH; Ahonen J; Neuvonen PJ; Olkkola KT
Eur J Anaesthesiol; 2005 Oct; 22(10):795-9. PubMed ID: 16211753
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of lidocaine and its metabolite as a hepatic function marker in dogs.
Pérez-Guillé BE; Villegas-Alvarez F; Toledo-López A; Jiménez-Bravo MA; González-Zamora JF; Carrasco-Portugal MC; Flores-Murrieta FJ; Soriano-Rosales RE
Proc West Pharmacol Soc; 2011; 54():62-5. PubMed ID: 22423583
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.
Muñoz AE; Miguez C; Rubio M; Bartellini M; Levi D; Podestá A; Niselman V; Terg R
Dig Dis Sci; 1999 Apr; 44(4):789-95. PubMed ID: 10219840
[TBL] [Abstract][Full Text] [Related]
17. Assessment of liver function in children with acute lymphoblastic leukemia in remission.
Mokrzycka M; Pawlik A; Kałdońska M; Millo B
Ann Acad Med Stetin; 2006; 52(3):61-5; discussion 65. PubMed ID: 17385349
[TBL] [Abstract][Full Text] [Related]
18. [Effect of dopamine on lidocaine metabolism in patients after partial liver resection--a pharmacokinetic analysis].
Takata T
Masui; 1989 Mar; 38(3):357-65. PubMed ID: 2739068
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of lidocaine and its major metabolite- monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction.
Wójcicki J; Sulikowski T; Wójcicki M; Droździk M; Gawrońska-Szklarz B; Barcew-Wiszniewska B; Skowron J; Rózewicka L; Gołdyn U
Eur J Drug Metab Pharmacokinet; 1995; 20(2):119-23. PubMed ID: 8582436
[TBL] [Abstract][Full Text] [Related]
20. Influence of hydralazine on the pharmacokinetics of orally administered d-propranolol and lidocaine in conscious dogs.
Heinzow BG; Somogyi A; McLean AJ
Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):5-14. PubMed ID: 3592861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
